STEFANOVICH ROBERT 4
4 · Cryoport, Inc. · Filed Mar 19, 2024
Insider Transaction Report
Form 4
Cryoport, Inc.CYRX
STEFANOVICH ROBERT
CFO, Treasurer and Secretary
Transactions
- Sale
Common Stock
2024-03-15$15.43/sh−1,035$15,972→ 123,662 total - Award
Common Stock
2024-03-15+5,750→ 129,412 total - Exercise/Conversion
Restricted Stock Rights
2024-03-09−2,666→ 2,667 total→ Common Stock (2,666 underlying) - Award
Stock Option (right to buy)
2024-03-15+11,500→ 11,500 totalExercise: $16.70Exp: 2031-03-15→ Common Stock (11,500 underlying) - Sale
Common Stock
2024-03-11$16.35/sh−1,119$18,298→ 124,697 total - Exercise/Conversion
Common Stock
2024-03-09+2,666→ 125,816 total
Footnotes (5)
- [F1]Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.
- [F2]Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
- [F3]Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 15, 2025.
- [F4]The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2024.
- [F5]1/48 of options vest on the 15th of each month for forty-eight months beginning April 25, 2024.